Catastrophic antiphospholipid syndrome (APS) is caused by thrombotic vascular occlusions that affect both small and large vessels, producing ischemia in the affected organs as well as a systemic inflammatory response syndrome (SIRS). We report a case of a patient with idiopathic thrombocytopenic purpura (ITP) who developed massive cerebral ischemia due to this entity. Prompt and aggressive treatment may prevent and actually resolve lethal complications caused by this devastating syndrome.
Brandt JT, Triplett DA, Alving B., Scharrer I.Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/ Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 1995;74(4):1185-1190.
Finis A., Ssenyonjo H., Knopp U., et al. Infarction of the right hemisphere in a patient with antiphospholipid antibody syndrome. Acta Neurochir (Wien). 2005;147(9):997-1002; discussion 1002.
4.
Giner V., Oltra MR, Esteban MJ, et al. Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation. Clin Rheumatol. 2007;26(6):991-993.
5.
Chen WH, Lin HS, Kao YF, et al. Delayed catastrophic antiphospholipid syndrome after massive cerebral infarction. Neurocrit Care. 2007;7(2):148-151.
6.
Briley DP, Coull BM, Goodnight SH Jr.Neurological disease associated with antiphospholipid antibodies. Ann Neurol. 1989;25(3):221-227.
7.
Cervera R., Asherson RA, Font J.Catastrophic antiphospholipid syndrome. Rheum Dis Clin North Am.2006;32(3):575-590.
8.
Asherson RA, Espinosa G., Cervera R., et al. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann Rheum Dis. 2005;64(6):943-946.
9.
Asherson RA, Cervera R., de Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530-534.
10.
Champion RH, Rook A.Livedo reticularis. Proc R Soc Med. 1960;53:961-962.
11.
Kravitz MS, Shoenfeld Y.Thrombocytopenic conditionsautoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS. Am J Hematol.2005;80(3):232-242.
